Xyntha

Xyntha Indications/Uses

factor viii

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
Control and Prevention of Bleeding Episodes in Hemophilia A: XYNTHA, Antihemophilic Factor (Recombinant), Plasma/Albumin-Free, is indicated for the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia).
XYNTHA does not contain von Willebrand factor, and therefore is not indicated in patients with von Willebrand's disease.
Surgical Prophylaxis in Patients with Hemophilia A: XYNTHA, Antihemophilic Factor (Recombinant), Plasma/Albumin-Free, is indicated for surgical prophylaxis in patients with hemophilia A.
Pediatric Use: Xyntha is appropriate for use in children of all ages, including newborns.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in